FDA daily for Thursday, November 19, 2026
In this issue: 37 shortage updates, 7 approvals, 25 device decisions, 202 label changes and a new batch of complete response letters. 3 items touch categories MedGrid carries, and they come first.
For MedGrid's categories
Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.
- Sterile Water Injection
Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug
- TRETINOIN
ZYDUS LIFESCIENCES · TRETINOIN
- Invisible Sunscreen SPF 40
HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE · PARTICLE AESTHETIC SCIENCE LTD · TOPICAL
Drug shortages
FDA date:FDA updated 37 shortage entries on Wed, Nov 18: 37 status updates.
- Sterile Water Injection
Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug
- Ketorolac Tromethamine Injection
Fresenius Kabi USA, LLC · Unavailable · Reason: Other
- Midazolam Hydrochloride Injection
Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug
- Lidocaine Hydrochloride Injection
Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug
- Dextrose Monohydrate 5% Injection
Baxter Healthcare · Available
- Ropivacaine Hydrochloride Injection
Fresenius Kabi USA, LLC · Available
- Methotrexate Sodium Injection
Fresenius Kabi USA, LLC · Available
- Furosemide Injection
Baxter Healthcare · Available
- Bupivacaine Hydrochloride Injection
Fresenius Kabi USA, LLC · Available
- Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug
- Dexamethasone Sodium Phosphate Injection
Mylan Institutional, a Viatris Company · Available
- Dextrose Monohydrate 10% Injection
Fresenius Kabi USA, LLC · Limited Availability · Reason: Demand increase for the drug
- Lisdexamfetamine Dimesylate Capsule
Alvogen · Available
- Dexmedetomidine Hydrochloride Injection
Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug
Drug and biologic approvals
FDA date:On Thu, Nov 12 FDA approved 3 new applications (1 brand or biologic, 2 generic) and 4 supplements to existing ones.
- TRETINOIN
ZYDUS LIFESCIENCES · TRETINOIN
- AMIFAMPRIDINE PHOSPHATE
TEVA PHARMS INC · AMIFAMPRIDINE PHOSPHATE
- PEBRILZO
BIOCON BIOLOGICS INC · PERTUZUMAB
Device clearances and approvals
FDA date:FDA decided 17 510(k)s and 8 PMA decisions on Thu, Nov 5.
- OxySight for MolecuLightDX+
MolecuLight, Inc. · Cardiovascular
- Dura-Guard Dural Repair Patch
Synovis Life Technologies, Inc. (Baxter International Inc.) · Neurology
- ELEOS with NanoCept® Technology Limb Salvage System
Onkos Surgical, Inc. · Orthopedic
- OptionELITE Vena Cava Filter System; OptionELITE Vena Cava Filter 100cm System
Argon Medical Devices, Inc. · Cardiovascular
- ANNE Limb
Sibel Health · Cardiovascular
- 3D Anatomical Model
The Jacobs Institute · Radiology
- Easytech Reversed Shoulder System
FX Shoulder Solutions, Inc. · Orthopedic
- BioCharge
Nanofiber Solutions, LLC · General, Plastic Surgery
- Mix2Vial® transfer device
West Pharma. Services IL, Ltd. · General Hospital
- MAGNETOM Free.XL
Siemens Healthineers AG · Radiology
- Progreat Lambda 2.1Fr
Terumo Clinical Supply Co., Ltd. · Cardiovascular
- Merge Hemo (Model RCSV2 (v11.3))
Merge Healthcare Incorporated · Cardiovascular
- SF Push-in Anchor
Surgical Fusion Technologies GmbH · Orthopedic
- NeuroSheath
Perfuze, Ltd. · Cardiovascular
Label updates
FDA date:202 drug labels took effect on Thu, Nov 5; 1 of the 25 read for this issue is for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.
- Invisible Sunscreen SPF 40
HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE · PARTICLE AESTHETIC SCIENCE LTD · TOPICAL
- Clopidogrel Bisulfate
CLOPIDOGREL BISULFATE · PD-Rx Pharmaceuticals, Inc. · ORAL
- Oxycodone and Acetaminophen
OXYCODONE AND ACETAMINOPHEN · American Health Packaging · ORAL
- temazepam
TEMAZEPAM · Bryant Ranch Prepack · ORAL
- CYCLOSPORINE
CYCLOSPORINE · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · ORAL
- Warfarin Sodium
WARFARIN SODIUM · PD-Rx Pharmaceuticals, Inc. · ORAL
Complete response letters
FDA date:FDA published a new batch of complete response letters, the letters that explain why an application was not approved as submitted. 2026 now has 39 letters; the newest are below.
- Summit Therapeutics Inc. · BLA 761524
yy U.S. FOOD & DRUG ADMINISTRATION BLA 761524 COMPLETE RESPONSE Summit Therapeutics Inc. Attention: Darshan Gandhi Associate Director, Regulatory Affairs 601 Brickell Key Drive, Suite 1000 Miami, FL…
- Cristcot HCA LLC · NDA 220054
YN U.S. FOOD & DRUG ADMINISTRATION NDA 220054 COMPLETE RESPONSE Cristcot HCA LLC Attention: Jennifer Davagian President 9 Damonmill Square Suite 4A Concord, MA 01742 Dear Jennifer Davagian: Please re…
- SEIKAGAKU Corporation · BLA 761393
ADMINISTRATION ¢ YN U.S. FOOD & DRUG BLA 761393 COMPLETE RESPONSE SEIKAGAKU Corporation c/o PAREXEL International 2520 Meridian Parkway, Suite 100 Durham, NC 27713 Attention: Katherine Fertal US Agen…
- Xspray Pharma AB · NDA 216195
g U.S. FOOD & DRUG ADMINISTRATION a NDA 216195 COMPLETE RESPONSE Xspray Pharma AB c/o Lachman Consultant Services, Inc. Attention: Jennifer Leaming, MSRA, RAC US Agent; Principal Consultant 1600 Stew…
- SamChunDang Pharm. Co., Ltd. · BLA 761494
i Lk YN U.S. FOOD & DRUG ADMINISTRATION BLA 761494 COMPLETE RESPONSE SamChunDang Pharm. Co., Ltd. c/o PPD Development L.P. Attention: Prudence Ciardullo RA Senior Manager 3900 Parkway Plaza Morrisvil…
- ITM Solucin GmbH · NDA 218705
g U.S. FOOD & DRUG Naty ADMINISTRATION NDA 218705 COMPLETE RESPONSE ITM Solucin GmbH c/o Lumara Bio USA Inc. Attention: Tinya Sow, MHA US Agent, Director - US, Regulatory Lead 5 Vaughn Drive, Suite 3…
- Fresenius Kabi USA, LLC · NDA 220381/Original 2,NDA 220381
yy U.S. FOOD & DRUG ADMINISTRATION NDA 220381/Original 2 COMPLETE RESPONSE Fresenius Kabi USA, LLC Attention: Winnie Chen Regulatory Technical Manager Three Corporate Drive Lake Zurich, IL 60047 Dear…
- Apiject Systems Corp. · NDA 219107
PN U.S. FOOD & DRUG ADMINISTRATION NDA 219107 COMPLETE RESPONSE Apiject Systems Corp. Attention: Ashley Dynan Senior Director of Regulatory Affairs 2 High Ridge Park Stamford, CT 06905 Dear Ashley Dy…
- Jiangsu Hengrui Pharmaceuticals Co., Ltd. · BLA 761308
yy U.S. FOOD & DRUG ADMINISTRATION BLA 761308 COMPLETE RESPONSE Jiangsu Hengrui Pharmaceuticals Co., Ltd. c/o Hengrui U.S.A., Inc. Attention: Brahmaiah Kommanaboyina US Agent Head of U.S. Regulatory…
- Elevar Therapeutics Inc. · NDA 216586
i Lk YN U.S. FOOD & DRUG ADMINISTRATION NDA 216586 COMPLETE RESPONSE Elevar Therapeutics Inc. ATTENTION: Young-Sil (Anna) Yim Executive Director, Regulatory Affairs: 1 Bridge Plaza North, Suite 850 F…
FDA did not answer for Food and supplement recalls, Drug recalls, Device recalls while this issue was written; those sections will fill in on a later visit.
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
